Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 20;10(3):490.
doi: 10.3390/antiox10030490.

Development of Water-Insoluble Vehicle Comprising Natural Cyclodextrin-Vitamin E Complex

Affiliations

Development of Water-Insoluble Vehicle Comprising Natural Cyclodextrin-Vitamin E Complex

Shigesaburo Ogawa et al. Antioxidants (Basel). .

Abstract

Development of a novel antioxidant-delivery vehicle exerting biosafety has been attracting a great deal of interest. In this study, a vehicle comprising a natural composite consisting of vitamin E (α-tocopherol; Toc) and cyclodextrin (CD) additives was developed, directed toward aqua-related biological applications. Not only β-CD, but also γ-CD, tended to form a water-insoluble aggregate with Toc in aqueous media. The aggregated vehicle, in particular the γ-CD-added system, showed a remarkable sustained effect because of slow dynamics. Furthermore, a prominent cytoprotective effect by the γ-CD-Toc vehicle under the oxidative stress condition was confirmed. Thus, the novel vitamin E vehicle motif using γ-CD as a stabilizer was proposed, widening the usability of Toc for biological applications.

Keywords: cell viability; oxidative stress; radical scavenging; vehicle; vitamin E; γ-cyclodextrin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Molecular structures of (blue) a vitamin E (α-Tocopherol; Toc), a water-soluble artificial Toc analogue, 2,2,5,7,8-pentamethyl-6-chromanol (PMC), and (pink) natural cyclodextrin (CD) compounds used in this study.
Figure 2
Figure 2
Photographs for I and for a sample diluted from 30 mM to 10 mM of γ-CD, respectively.
Figure 3
Figure 3
Contained vitamin E (Toc) concentration in I as the function of (a) initial γ-cyclodextrin (CD) concentrations and (b) added total amount of Toc. For (a), the added amount of Toc was 1.2 times mole of γ-CD. For (b), the γ-CD concentration was constant at 30 mM.
Figure 4
Figure 4
Results of the ABTS radical scavenging test for sample I. (a) Time dependence measurement and (b) radical scavenging ability (RSA) after 12 h and 30 min for the γ-cyclodextrin (CD)-added systems. The β-CD and γ-CD concentrations were diluted from 10 mM and 30 mM for the test, respectively, and the measurement was performed for the CD concentrations below 0.8 mM.
Figure 5
Figure 5
Cytoprotective impact of the γ-cyclodextrin (CD)-vitamin E (Toc) complex in the presence of a cytotoxic oxidative stressor. (a) Viability of COS-7 cells cultured for 30 min in the presence or absence of γ-CD or γ-CD-Toc before exposure to 0, 50, 100, or 200 µM tert-butyl hydroperoxide (TBHP) for 18 h. Cell viability was measured using a Cell Counting Kit-8 (Dojindo Laboratories) (* p < 0.05). (b) Phase-contrast photomicrographs of COS-7 cells cultured for 30 min in the presence or absence of γ-CD or γ-CD-Toc before exposure to 0, 100, or 200 µM TBHP for 18 h. The red arrowhead indicates a dead cell.

Similar articles

Cited by

References

    1. Niki E., Abe K. Vitamin E: Structure, properties and functions. In: Niki E., editor. Food Chemistry, Function and Analysis No. 11 Vitamin E: Chemistry and Nutritional Benefits. The Royal Society of Chemistry; London, UK: 2019. pp. 1–11. Chapter 1. - DOI
    1. Melanie Z., Wallert M., Lorkowski S., Peter K. Cardiovascular and metabolic protection by vitamin E: A matter of treatment strategy? Antioxidants. 2020;9:935. doi: 10.3390/antiox9100935. - DOI - PMC - PubMed
    1. Gugliandolo A., Bramanti P., Mazzon E. Role of vitamin E in the treatment of Alzheimer’s disease: Evidence from animal models. Int. J. Mol. Sci. 2017;18:2504. doi: 10.3390/ijms18122504. - DOI - PMC - PubMed
    1. Lloret A., Esteve D., Monllor P., Cervera-Ferri A., Lloret A. The effectiveness of vitamin E treatment in Alzheimer’s disease. Int. J. Mol. Sci. 2019;20:879. doi: 10.3390/ijms20040879. - DOI - PMC - PubMed
    1. Lewis E.D., Meydani S.N., Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. 2019;71:487–494. doi: 10.1002/iub.1976. - DOI - PMC - PubMed

LinkOut - more resources